MUG-Chor1 Cells
USD$375.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MUG-Chor1 cell line is a well-characterized in vitro model derived from a recurrent sacrococcygeal chordoma in a Caucasian female patient. Chordomas are rare, malignant tumors that arise from remnants of the notochord along the axial skeleton. MUG-Chor1 was established through mechanical and enzymatic disaggregation of the tumor tissue and cultured under optimized conditions to sustain its growth. The cell line retains the hallmark features of chordoma, including the expression of brachyury, a transcription factor essential for notochordal differentiation and a diagnostic marker for chordomas. Additionally, MUG-Chor1 expresses cytokeratins, EMA, vimentin, and S-100 proteins, further validating its chordoma origin. Genetically, MUG-Chor1 mirrors the chromosomal and molecular alterations typical of chordomas, including gains at the brachyury (T) locus on chromosome 6q27 and losses at 9p24.3-p13.1, encompassing the CDKN2A/CDKN2B loci. It also demonstrates deletions at loci such as 10q25.2, which includes PTEN, and other regions associated with tumor progression. These genetic characteristics make MUG-Chor1 a valuable tool for studying chordoma biology and for evaluating therapeutic interventions. The slow growth rate of MUG-Chor1, with a doubling time of 7-10 days, reflects the clinical behavior of chordomas, which are known for their indolent but locally aggressive nature. This cell line has been pivotal in preclinical research, including drug screening studies that have identified potential therapeutic agents, such as EGFR inhibitors. These inhibitors have demonstrated efficacy in reducing cell viability and tumor growth in chordoma models, underscoring the relevance of MUG-Chor1 for translational studies. |
|---|---|
| Organism | Human |
| Tissue | Bone, sacrum |
| Disease | Sacral chordoma |
| Synonyms | MUG-CHOR1, MUGCHOR1, Medical University of Graz-Chordoma 1 |
Characteristics
| Age | 57 years |
|---|---|
| Gender | Female |
| Ethnicity | Unspecified |
| Morphology | Mesenchymal-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | MUG-Chor1 (Cytion catalog number 305478) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_9277 |
Biomolecular Data
Handling
| Culture Medium | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|